Miniject is iSTAR Medical’s innovative microinvasive glaucoma surgery (MIGS) device for patients with primary open-angle glaucoma.
Miniject combines the distinctive porous structure of its proprietary Star material with the power offered by the supraciliary space. As a result, it is designed to enhance natural fluid outflow, reducing intraocular pressure (IOP) and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis, and subsequent complications.
Three-year follow-up results demonstrate sustained, meaningful, mean IOP reduction of 36%, with 42% of patients medication-free. Mean endothelial cell density loss at three years was 9% (less than for cataract surgery at two years).1
Contact: istar-medical.com
Reference
- Provisional interim results up to three years. Data on file.
